ArticleInternational journal of clinical pharmacy2023

Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System.

Xiaotong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.